EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

AZ's new obesity pill shows promise, enters phase II

AstraZeneca’s new weight-loss pill, licensed from China’s Eccogene last year, has shown initial promise in early-stage trials.
The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: October 2024

Catch up on all the biggest news to hit the pharmaceutical industry last month, spanning from new acquisitions, approvals, insights on the NHS and more.
5 stars

Boehringer, Amgen and Novartis rank top for cardiovascular patient groups

Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.

Sustainable pharma packaging takes a big step forward

UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.

ABPI welcomes the UK Chancellor’s new Budget

The Association of the British Pharmaceutical Industry has expressed support for the first Labour budget in 14 years.
Vaccines on blue background

CDC panel backs expanded use of pneumococcal vaccines in adults

Pfizer and Merck’s pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up a new market.
Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.
Gold crown on blue background

HCPs rank pharma in top sectors for trust, says Ipsos

Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.